MetaCap

CytomX Therapeutics (CTMX) Stock Chart

NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.55-0.01 (-0.39%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CTMX technical summary

CTMX is trading 19.3% below its 50-day simple moving average of $3.16 and 36.8% below its 200-day average of $4.03. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 32.3, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $2.48 (Oct 5, 2026) to $8.21 (Mar 16, 2026); the current price sits 1% of the way from the low to the high. Annualized 30-day volatility is 72.2%. Based on the last session's high, low and close, the classic pivot point is $2.57, with first resistance at $2.63 and first support at $2.50.

These indicators describe past price behavior for CytomX Therapeutics; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
8.21 (Mar 16)
1Y low
2.48 (Oct 5)
Last close
2.55

CTMX price performance

1 week

-6.25%

1 month

-30.14%

3 months

-33.42%

6 months

-40.00%

Year to date

-40.14%

1 year

-23.42%

3 years

+104.00%

5 years

-50.39%

CTMX price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day2.58Price below2.59Price below
10-day2.65Price below2.66Price below
20-day2.79Price below2.81Price below
50-day3.16Price below3.08Price below
100-day3.30Price below3.35Price below
200-day4.03Price below3.75Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)2.76
Resistance 2 (R2)2.70
Resistance 1 (R1)2.63
Pivot point2.57
Support 1 (S1)2.50
Support 2 (S2)2.44
Support 3 (S3)2.37

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis